CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Diagnos Laboratorium Utama PT Tbk is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Diagnos Laboratorium Utama PT Tbk
Jakartalaboratory
Jl. Teuku Cik Ditiro No.28 Central
Phone: +62 213193183p:+62 213193183 JAKARTA, Indonesia Ticker: DGNSDGNS

Business Summary
PT Diagnos Laboratorium Utama Tbk is an Indonesia-based company that is engaged in providing health services using laboratories. The Company’s scope of activities also includes private clinical activities. Its products and services include clinical pathology laboratory tests, anatomical pathology laboratory tests, genomics laboratory tests, homecare health tests, corporate health tests and Covid-19 tests. Its clinical pathology laboratory provides services ranging from molecular examinations to support more treatment. Its clinical pathology laboratory provides services for examination of hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology and microbiology. The services provided at the genetic laboratory are non-invasive prenatal testing (NIPT), preimplantation genetic testing for aneuploidy (PGT-A) services, and preimplantation genetic testing for monogenic diseases (PGT-M) services. Its homecare health services provide health checks that are done at home.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President Commissioner Ivan R.Sini 50
President Director Mesha R.Sini 49
Director - Finance, Accounting & IT FergusRichard 31 7/20/2022 7/20/2022
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 64 (As of 12/31/2023)
Outstanding Shares: 1,250,000,000 (As of 12/31/2023)
Stock Exchange: JAK


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 29, 2024